Cargando…

Reduction of Lipid-Core Burden Index in Nonculprit Lesions at Follow-Up after ST-Elevation Myocardial Infarction: A Randomized Study of Bioresorbable Vascular Scaffold versus Optimal Medical Therapy

BACKGROUND: Non-flow-limiting nonculprit lesions (NCL) that contain a large lipid-rich necrotic core (nonculprit lipid-rich plaques (NC-LRP)) are most likely to cause recurrent acute coronary syndrome after ST-elevation myocardial infarction (STEMI). Near-infrared spectroscopy (NIRS) detects LRPs us...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kefer, Joelle, Chenu, Patrick, Gurné, Olivier, Maes, Frederic, Tamakloé, Théophile, Beauloye, Christophe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266479/ https://www.ncbi.nlm.nih.gov/pubmed/34290573 http://dx.doi.org/10.1155/2021/5590093

Ejemplares similares

Optimal Timing of Percutaneous Coronary Intervention for Nonculprit Vessel in Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
por: Kim, Inna, et al.
Publicado: (2017)

Effect of ramipril on progression of nonculprit lesions in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention
por: Wang, Jian, et al.
Publicado: (2019)

Bioresorbable vascular scaffolds in acute ST-segment elevation myocardial infarction: a prospective multicentre study ‘Prague 19’
por: Kočka, Viktor, et al.
Publicado: (2014)

Interventional Treatment of Nonculprit Lesions in Infarct‐Related Cardiogenic Shock
por: Desch, Steffen, et al.
Publicado: (2019)

Thrombosis and myocardial infarction: the role of bioresorbable scaffolds
por: Leesar, Massoud A., et al.
Publicado: (2023)

Evolution of nonculprit coronary atherosclerotic plaques assessed by serial virtual histology intravascular ultrasound in patients with ST-segment elevation myocardial infarction and chronic total occlusion
por: Kang, Jeehoon, et al.
Publicado: (2016)

Impact of COVID‐19 pandemic on the management of nonculprit lesions in patients presenting with ST‐elevation myocardial infarction: Outcomes from the pan‐London heart attack centers
por: Demir, Ozan M., et al.
Publicado: (2021)

Comparison of the everolimus-eluting bioresorbable vascular scaffold versus the everolimus-eluting metallic stent in real-world patients with ST-segment elevation myocardial infarction
por: Desperak, Piotr, et al.
Publicado: (2020)

Bioresorbable scaffolds: everything resolved?
por: Appelman, Yolande
Publicado: (2015)

Bioresorbable Scaffolds for Atheroregression: Understanding of Transient Scaffolding
por: N. Kharlamov, M.D., Alexander
Publicado: (2016)

Angiographically Based Direct Implantation of the Bioresorbable Vascular Scaffold in Non-ST Segment Elevation Acute Coronary Syndrome: Feasibility and Outcome
por: Nour, Mahmoud Khaled, et al.
Publicado: (2019)

Bioresorbable scaffolds for percutaneous coronary interventions
por: Gogas, Bill D.
Publicado: (2014)

Bioresorbable Polymeric Scaffold in Cardiovascular Applications
por: Toong, Daniel Wee Yee, et al.
Publicado: (2020)

Bioresorbable scaffolds in the treatment of coronary artery disease
por: Zhang, Yaojun, et al.
Publicado: (2013)

Vascular restoration therapy and bioresorbable vascular scaffold
por: Wang, Yunbing, et al.
Publicado: (2014)

Bioresorbable vascular scaffolds: between promises and reality
por: Montone, Rocco A., et al.
Publicado: (2017)

In vivo degradation and endothelialization of an iron bioresorbable scaffold
por: Lin, Wenjiao, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Current Technology and Future Perspectives
por: Forrestal, Brian, et al.
Publicado: (2020)

Bioresorbable Scaffolds: Contemporary Status and Future Directions
por: Peng, Xiang, et al.
Publicado: (2020)

Coronary Aneurysm Formation After Bioresorbable Vascular Scaffold Implantation Resulting in Acute Myocardial Infarction
por: Fang, Ching-Chang, et al.
Publicado: (2017)

One-year efficacy and safety of everolimus-eluting bioresorbable scaffolds in the setting of acute myocardial infarction
por: Kim, Yongcheol, et al.
Publicado: (2020)

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial
por: Sabaté, Manel, et al.
Publicado: (2016)

Fully bioresorption of an Absorb bioresorbable vascular scaffold after scaffold restenosis
por: Goncalves-Ramírez, Luis R., et al.
Publicado: (2019)

Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study
por: Lhermusier, Thibault, et al.
Publicado: (2019)

Bioresorbable Scaffolds: Current Evidence and Ongoing Clinical Trials
por: Bourantas, Christos V., et al.
Publicado: (2012)

Bioresorbable vascular scaffold: promises and the fallen child-as-king?
por: Cook, Stephane, et al.
Publicado: (2016)

Bioresorbable Vascular Scaffold Korean Expert Panel Report
por: Ahn, Jung-Min, et al.
Publicado: (2017)

Bioresorbable Scaffolds in Coronary Intervention: Unmet Needs and Evolution
por: Capodanno, Davide
Publicado: (2017)

Very-long-term efficacy of bioresorbable vascular scaffolds
por: Shah, R.
Publicado: (2017)

In vitro and in vivo degradation of microfiber bioresorbable coronary scaffold
por: Huang, Chi‐Hung, et al.
Publicado: (2017)

Neoatherosclerosis　― Long-Term Assessment of Bioresorbable Vascular Scaffold ―
por: Moriyama, Noriaki, et al.
Publicado: (2019)

Gender differences in plaque characteristics of nonculprit lesions in patients with coronary artery disease
por: Tian, Jiangtian, et al.
Publicado: (2019)

Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction
por: Plein, Sven, et al.
Publicado: (2008)

Physiology-guided revascularization versus optimal medical therapy of nonculprit lesions in elderly patients with myocardial infarction: Rationale and design of the FIRE trial
por: Biscaglia, Simone, et al.
Publicado: (2020)

The natural course of nonculprit coronary artery lesions; analysis by serial quantitative coronary angiography
por: Kang, Jeehoon, et al.
Publicado: (2018)

Lipoprotein (a) levels and vulnerable characteristics in nonculprit plaque in patients with acute coronary syndrome()
por: Kato, Ayami, et al.
Publicado: (2022)

Bioresorbable Vascular Scaffold Use in a Case of In-stent Restenosis
por: Cadrin-Tourigny, Julia, et al.
Publicado: (2014)

Bioresorbable scaffolds: a new paradigm in percutaneous coronary intervention
por: Tenekecioglu, Erhan, et al.
Publicado: (2016)

Bioresorbable vascular scaffold: a step back thinking of the future
por: Polimeni, Alberto, et al.
Publicado: (2018)

Delayed neointimal healing pattern after bioresorbable scaffold implantation
por: Ochijewicz, D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qh91rtjglq4vvob1hv56k6li6h